专利号:US-2022125711-A1 优先权日:2020-10-23 标题 :Cannabinoid-containing oral thin film formulations 发明人:BAJAJ AKHIL; WEBB SKYLER; HOOSEIN SHEHZAD; RASHKOW ANDREW 权利人:JDEM PROPERTIES LLC 摘要:The methods disclosed herein permit the synthesis of cannabinoid-containing oral thin film (OTF) strips that also contain caffeine or multiple additional active ingredients. Selection of film forming agents based on water usage coupled with low temperature mixing and low temperature drying may in various embodiments permit the incorporation of up to five additional ingredients into a cannabinoid containing OTF product.
专利号:CN-114524765-A 优先权日:2021-12-27 标题 :A kind of method for base-catalyzed synthesis of doxylamine succinate
专利号:US-2005053642-A1 优先权日:2000-08-23 标题:Biocompatible materials 发明人:ULBRICHT MATHIAS; THOM VOLKMAR; JANKOVA KATJA; ALTANKOV GEORGE; JONSSON GUNNAR 摘要:The present invention teaches a novel approach of creating biocmpatible surfaces, said surfaces being capable of functionally interact with biological material. SAid biocompatible surfaces comrise at least two comonents, such as a hydrophobic substratum and a macromolecule of hydrophilic nature, which, in a cooperativity, form together the novel biocoompatible surfaces. The novel approach is ased on contacting said hydrophobic substratum with a laterally patterned monomolecular layer of said hydrophilic and flexible macromolecules, exhibiting a pronounced excluded volume. The htus formed two component surface is, in respect to polarity and morphology, a molecularly heterogeneous surface. Structural features of said macromolecular monolayer (as e.g. the layer thickness or its lateral density) are determined by: i) the structural features of the layer forming macromolecules (as e.g. their MW or their molecular architecture) and ii) the method of creating said monomolecular layer (as e.g. by physi- or chemisorbing, or by chemically binding said macromolecules). The structural features of the layer forming macromolecules(s) is in turn determined by synthesis. AMount and conformation and thus also biological activity of biological material (as e.g. polypeptides) which contact the novel biocompatible surface, is determined and maintained by the cooperative action of the underlying hydrophobic substratum and the macromolecular layer. In this way it becomes possible to maintain and control biological interactions between said contacted polypeptides and other biological compounds as e.g. cells, antibodies and the like. Consequently, the present invention aims to reduce and/or eliminate the deactivation and/or denaturation associated with the contacting of polypeptides and/or other biological material to a hydrophobic substratum surface.
专利号:CN-110498764-B 优先权日:2019-09-25 标 题:A kind of synthesis method of doxylamine succinate
1: Pope E, Maltepe C, Koren G. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study. J Clin Pharmacol. 2015 Jul;55(7):809-14. doi: 10.1002/jcph.480. Epub 2015 Mar 27. doi: 10.2147/IJWH.S46653. eCollection 2014. Review. 3: Koren G, Vranderick M, Gill SK, Macleod S. Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate-pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy. J Clin Pharmacol. 2013 Dec;53(12):1268-76. doi: 10.1002/jcph.184. Epub 2013 Oct 10. doi: 10.1310/hpj4809-762. 5: Nulman I, Koren G. Pharmacokinetic comparison of a delayed-release combination of doxylamine succinate and pyridoxine hydrocholoride (Diclectin) and oral solutions of these drugs in healthy women of childbearing age. Can J Clin Pharmacol. 2009 Fall;16(3):e400-6. Epub 2009 Oct 29. Review. German. French. doi: 10.1016/j.talanta.2006.02.023. Epub 2006 Mar 20. doi: 10.4103/0250-474X.44607.
合成参考文献
摘要:Journal of the American Pharmaceutical Association, Scientific Edition., 37(311), 1948 摘要:Journal of Laboratory and Clinical Medicine., 33(325), 1948 参考文献:10.1007/s001050050915 摘要:Brockow K, Abeck D, Ring J. [Systemic therapy in the treatment concept of atopic eczema. Reliable treatment methods and experimental developments]. Hautarzt. 1999 May;50(5):323–9. doi: 10.1007/s001050050915.